162 related articles for article (PubMed ID: 19787329)
1. [Imaging procedures for gastrointestinal stromal tumors].
Antoch G; Herrmann K; Heusner TA; Buck AK
Radiologe; 2009 Dec; 49(12):1109-16. PubMed ID: 19787329
[TBL] [Abstract][Full Text] [Related]
2. [Importance of PET for surgery of gastrointestinal stromal tumors].
Ronellenfitsch U; Wängler B; Niedermoser S; Dimitrakopoulou-Strauss A; Hohenberger P
Chirurg; 2014 Jun; 85(6):493-9. PubMed ID: 24823996
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
4. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
Hahn S; Bauer S; Heusner TA; Ebeling P; Hamami ME; Stahl A; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Dec; 80(3):670-4. PubMed ID: 20970938
[TBL] [Abstract][Full Text] [Related]
5. F-18 FDG PET, CT, and MRI for detecting the malignant potential in patients with gastrointestinal stromal tumors: A protocol for a network meta-analysis of diagnostic test accuracy.
Wei K; Pan B; Yang H; Lu C; Ge L; Cao N
Medicine (Baltimore); 2018 Apr; 97(16):e0389. PubMed ID: 29668594
[TBL] [Abstract][Full Text] [Related]
6. Imaging findings of primary malignant gastrointestinal stromal tumor of the liver.
Kim HO; Kim JE; Bae KS; Choi BH; Jeong CY; Lee JS
Jpn J Radiol; 2014 Jun; 32(6):365-70. PubMed ID: 24682930
[TBL] [Abstract][Full Text] [Related]
7. Unusual loss of FDG uptake in recurrent GIST.
Dunzinger A; Decker J; Kieberger A; Weis S; Pichler R
Nuklearmedizin; 2014 Aug; 53(4):N35-7. PubMed ID: 25100559
[No Abstract] [Full Text] [Related]
8. Role of F-18-FDG-PET/CT in restaging of patients affected by gastrointestinal stromal tumours (GIST).
Bertagna F; Bosio G; Orlando E; Biasiotto G; Giubbini R
Nucl Med Rev Cent East Eur; 2010; 13(2):76-80. PubMed ID: 21598231
[TBL] [Abstract][Full Text] [Related]
9. Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy.
Boonsirikamchai P; Podoloff DA; Choi H
Hematol Oncol Clin North Am; 2009 Feb; 23(1):35-48, vii. PubMed ID: 19248969
[TBL] [Abstract][Full Text] [Related]
10. Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group.
Kalkmann J; Zeile M; Antoch G; Berger F; Diederich S; Dinter D; Fink C; Janka R; Stattaus J;
Cancer Imaging; 2012 May; 12(1):126-35. PubMed ID: 22572545
[TBL] [Abstract][Full Text] [Related]
11. How I do it: surgical management of gastrointestinal stromal tumors.
Raut CP; Ashley SW
J Gastrointest Surg; 2008 Sep; 12(9):1592-9. PubMed ID: 18317848
[TBL] [Abstract][Full Text] [Related]
12. Utility of positron emission tomography in sarcomas.
Schuetze SM
Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
[TBL] [Abstract][Full Text] [Related]
13. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
14. ¹⁸F-FDG PET/CT and contrast enhanced CT in differential diagnosis between leiomyoma and gastrointestinal stromal tumor.
Hirose Y; Kaida H; Kawahara A; Kurata S; Ishibashi M; Abe T
Hell J Nucl Med; 2015; 18(3):257-60. PubMed ID: 26574696
[TBL] [Abstract][Full Text] [Related]
15. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
[TBL] [Abstract][Full Text] [Related]
16. [GIST: Imaging diagnosis, staging, and response assessment].
Schima W; Kurtaran A
Wien Med Wochenschr; 2009; 159(15-16):408-13. PubMed ID: 19696986
[TBL] [Abstract][Full Text] [Related]
17. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
18. Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.
Chacón M; Eleta M; Espindola AR; Roca E; Méndez G; Rojo S; Pupareli C
Future Oncol; 2015; 11(6):953-64. PubMed ID: 25760976
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma.
Judson I; Scurr M; Gardner K; Barquin E; Marotti M; Collins B; Young H; Jürgensmeier JM; Leahy M
Clin Cancer Res; 2014 Jul; 20(13):3603-12. PubMed ID: 24714778
[TBL] [Abstract][Full Text] [Related]
20. Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib.
Shinto A; Nair N; Dutt A; Baghel NS
Clin Nucl Med; 2008 Jul; 33(7):486-7. PubMed ID: 18580237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
